FDA restricts Johnson & Johnson COVID-19 vaccine due to blood clot risk
U.S. regulators on Thursday strictly limited who can receive Johnson & Johnson's COVID-19 vaccine due to the ongoing risk of rare but serious blood clots.
The Food and Drug Administration said the shot should only be given to adults who cannot receive a different vaccine or specifically request J&J's vaccine. U.S. authorities for months have recommended that Americans starting their COVID-19 vaccinations use the Pfizer or Moderna shots instead.
Restricted use of COVID-19 Vaccine Due to Blood Clot Risk
This website uses cookies to manage authentication, navigation, and other functions. By using our website, you agree that we can place these types of cookies on your device.
A cookie is a text file being stored in your device: Computer, Smartphone, etc.
Be aware if you decline to store cookies you will neither be able to Register or Login!
This website uses cookies to manage authentication, navigation, and other functions. By using our website, you agree that we can place these types of cookies on your device.
A cookie is a text file being stored in your device: Computer, Smartphone, etc.
Be aware if you decline to store cookies you will neither be able to Register or Login!